Aarti Pharmalabs Ltd.

Aarti Pharmalabs has informed that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 to consider and approve Audited Financial Results of the Company for the quarter and nine-months ended December 31, 2024 after these results are reviewed by the Audit Committee of the Board; Declaration of Interim Dividend, if any, on the equity share capital of the Company for the Financial Year 2024-25. 

The above information is a part of company’s filings submitted to BSE.